Crossmark

Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil

Crossref DOI link: https://doi.org/10.1007/s13318-018-0488-4

Published Online: 2018-06-11

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hard, Marjie L.

Wehr, Angela Y.

Sadler, Brian M.

Mills, Richard J.

von Moltke, Lisa
Funding

Funding for this research was provided by:

Alkermes, Inc.
License Information

Text and Data Mining valid from 2018-06-11
More Information

Article History

First Online: 11 June 2018

Compliance with Ethical Standards

:

: This study was sponsored by Alkermes, Inc., Waltham, MA, USA. Funding for editorial support for manuscript preparation was provided by Alkermes, Inc., Waltham, MA, USA.

: Marjie Hard is a former employee of Alkermes, Inc. Angela Wehr and Lisa von Moltke are employees of Alkermes, Inc. Brian Sadler and Richard Mills are employees of ICON plc who performed the work under contract to Alkermes, Inc.

Document is current

Any future updates will be listed below